Cargando…
Guidelines for Rational and Cost-Effective Use of iNO Therapy in Term and Preterm Infants
Inhaled nitric oxide (iNO) is an effective but costly therapy for infants with hypoxemic respiratory failure. The approved and solidly evidence-based indication is for treatment of late preterm and term infants with persistent pulmonary hypertension of the newborn (PPHN); however, off-label use of i...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743146/ https://www.ncbi.nlm.nih.gov/pubmed/24027689 http://dx.doi.org/10.4103/2249-4847.96739 |